| 发明名称 |
FORMULATION |
| 摘要 |
The present invention relates to a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation may be used for intravenous or parenteral administration. |
| 申请公布号 |
CA2915199(A1) |
申请公布日期 |
2016.06.17 |
| 申请号 |
CA20152915199 |
申请日期 |
2015.12.14 |
| 申请人 |
PFIZER INC. |
发明人 |
BACK, KEVIN RICHARD;CRAM, MICHAEL;HARPER, AIDAN JAMES;LILLIS, JONATHAN RICHARD;LUTHRA, SUMIT;HUANG, W. JAMES;LUKAS, TIMOTHY MICHAEL |
| 分类号 |
C07D401/12;A61K9/19;A61K31/53 |
主分类号 |
C07D401/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
